Related Experiment Video
Updated: Jul 24, 2025

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Natural Product BO-1 as an Inner Responsive Molecule Inhibits Antimicrobial-Resistant Staphylococcus aureus via
Chuan-Yun Xiao1, Jiao Huang1, Xiao Liu1
1School of Pharmacy, Fudan University, Shanghai 201203, China.
A novel compound, BO-1, from Piper betle L. synergizes with antibiotics to combat multidrug-resistant Staphylococcus aureus. This inner responsive molecule (IRM) inhibits efflux activity, restoring antibiotic sensitivity and reducing inflammation in animal models.
Area of Science:
- Microbiology
- Pharmacology
- Natural Products Chemistry
Background:
- Multidrug-resistant Staphylococcus aureus (MRSA) poses a significant global health threat, necessitating novel therapeutic strategies.
- Existing antibiotics are becoming less effective due to bacterial resistance mechanisms, particularly efflux pumps.
- Inner responsive molecules (IRMs) are hypothesized to restore antibiotic sensitivity without inducing further resistance.
Purpose of the Study:
- To identify and characterize IRMs from Piper betle L. that can synergize with antibiotics against MRSA.
- To elucidate the mechanism of action of identified IRMs, focusing on resistance suppression.
- To evaluate the therapeutic potential of IRM-antibiotic combinations in preclinical models.
Main Methods:
- Extraction and isolation of compounds from Piper betle L. using chromatographic techniques.
- In vitro testing of isolated compounds for synergistic antibacterial activity against resistant S. aureus strains.
- Mechanistic studies involving efflux inhibition assays and resistance reversal experiments.
- In vivo efficacy evaluation in animal models of S. aureus infection, assessing bacterial load and inflammatory markers.
Main Results:
- Six benzoate esters (BO-1 to BO-6) were isolated from Piper betle L. extract.
- BO-1 demonstrated significant synergistic activity, potentiating ciprofloxacin's efficacy against multiple resistant S. aureus strains.
- Mechanistic studies confirmed BO-1 acts as an efflux inhibitor, suppressing drug resistance.
- Combination therapy with BO-1 and ciprofloxacin reversed antibiotic resistance and reduced inflammatory markers (IL-6, C-reactive protein) in infected mice.
Conclusions:
- BO-1 is a potent IRM capable of restoring antibiotic sensitivity in multidrug-resistant S. aureus by inhibiting efflux pumps.
- The combination of BO-1 with ciprofloxacin offers a promising strategy to overcome antibiotic resistance and treat S. aureus infections.
- Piper betle L. serves as a valuable source for novel compounds with potential applications in combating antimicrobial resistance.
More Related Videos
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
11:59Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
Published on: May 15, 2019
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Effectiveness
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...